Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GS-493 |
| Synonyms | |
| Therapy Description |
GS-493 is a catalytic-site inhibitor of Shp2, which may result in decreased cell growth and inhibition of tumor growth (PMID: 25877780). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GS-493 | GS493|GS 493 | SHP2 Inhibitor 20 | GS-493 is a catalytic-site inhibitor of Shp2, which may result in decreased cell growth and inhibition of tumor growth (PMID: 25877780). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|